NCT05447169 Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening
| NCT ID | NCT05447169 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Nasopharyngeal Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 11,625 participants |
| Start Date | 2022-07-10 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 11,625 participants in total. It began in 2022-07-10 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators intend to compare Epstein-Barr virus antibody and Epstein-Barr virus DNA screening efficacy in first-degree relatives of nasopharyngeal carcinoma patients.
Eligibility Criteria
Inclusion Criteria: * residents in Southern China * 30-62 years old * male * a first-degree relative of at least one nasopharyngeal carcinoma patient * no medical record of nasopharyngeal carcinoma * Eastern Cooperative Oncology Group score of 0-2 * be able to comprehend, sign, and date the written informed consent document to participate in the study Exclusion Criteria: * history of nasopharyngeal carcinoma * heavy cardiovascular, liver or kidney disease * on systemic steroid or immunosuppressant treatment or active autoimmune disease
Contact & Investigator
Ming-Yuan Chen, MD, PhD
STUDY CHAIR
Sun Yat-sen University
Frequently Asked Questions
Who can join the NCT05447169 clinical trial?
This trial is open to male participants only, aged 30 Years or older, up to 62 Years, studying Nasopharyngeal Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05447169 currently recruiting?
Yes, NCT05447169 is actively recruiting participants. Contact the research team at chmingy@mail.sysu.edu.cn for enrollment information.
Where is the NCT05447169 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT05447169 clinical trial?
NCT05447169 is sponsored by Sun Yat-sen University. The principal investigator is Ming-Yuan Chen, MD, PhD at Sun Yat-sen University. The trial plans to enroll 11,625 participants.